The popularity of weight loss drugs like Ozempic and Mounjaro has surged, causing shortages and a black market. Patients, including those with diabetes, are struggling to access their prescriptions. The demand for these drugs is impacting vulnerable individuals and the industry, leading to concerns about potential risks and availability. Some older drugs are still available but may offer less benefit at a lower price. The rise in demand has also led to the emergence of 'Ozempic babies' and shortages of Lilly's new weight-loss drug Zepbound.
An emotional multi-billion dollar battle is being fought over who gets access to the revolutionary weight loss drug and the availability of ‘chemists own’ versions in Australia. FULL STORY: https://t.co/ZtLh8J1wll https://t.co/6h9uDqYVZl
How Ozempic, weight-loss drugs force health enthusiasts to change https://t.co/1yvdE18Ljb
Have you tried getting Ozempic and Mounjaro? These prescription drugs are at the center of a diet trend. We investigate the skyrocketing demand and the potential impact to the industry and some patients. Watch @CandiceNguyenTV ’s full report now. https://t.co/xQwBUHyqQr https://t.co/Opu2i9TxS9
Ozempic, weight-loss drugs rise and the fitness industry reacts https://t.co/cRO9hqa3wn
Before getting a call from Carlos Balladares in Concord, I didn't know asking for an Ozempic, Wegovy or Mounjaro Rx for cosmetic weight loss could negatively impact vulnerable patients like him. Now I know. Here’s his story: https://t.co/F2c2yKWDep -@nbcbayarea
Rite Aid and Amazon confirmed that Lilly’s new weight-loss drug Zepbound is in short supply https://t.co/8YoYcpzxr6
'Ozempic babies' are the latest phenomenon attributed to viral diabetes and dieting drug, The run on Ozempic has led to nation-wide shortages. https://t.co/JrZD9gzxPz
"This is for people with diabetes, not to lose weight." The skyrocketing popularity of weight loss drugs like Ozempic and Mounjaro is making it nearly impossible for some diabetes patients to access their prescriptions. https://t.co/MOQdMkY8pD
Ozempic, Mounjaro, Wegovy negative impacts: Drug shortages & black market. We speak to a @Stanford MD about the risk of buying these diet drugs online, and a diabetes patient who has a Rx but pharmacies have been out for months. - @nbcbayarea https://t.co/F2c2yKW5oR
“Older drugs—among them Qsymia, Orlistat, and Contrave—are still available. Indeed, the best of these latter treatments might produce, on average, one-half the benefit you’d get from using GLP-1s in terms of weight loss, at less than one-30th the price.” https://t.co/Mle9FEpIsQ
The skyrocketing popularity of weight loss drugs like Ozempic and Mounjaro is making it nearly impossible for some diabetes patients to access their prescriptions, according to one of the drug manufacturers and local endocrinologists. https://t.co/6fykKV8aNC
Have you tried getting Ozempic and Mounjaro? Have you thought of trying to get them? These prescription drugs are at the center of a diet trend. We investigate the skyrocketing demand and the potential impact to the industry and some patients. Watch at 11 p.m. on NBC Bay Area. https://t.co/JzkWifae4X
Have you thought of trying to get #Ozempic to shed some weight? It sounds like the magic pill many of us have been waiting for! #WeInvestigate the impact this skyrocketing demand is having on some vulnerable patients & concerns of a black market. Tonight at 11 on @nbcbayarea. https://t.co/L35DqoF08H